- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03420716
Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women
February 1, 2018 updated by: Carmen Marino Donangelo, Universidad de la Republica
Effect of Regular Consumption of a Symbiotic Yogurt on Calcium Absorption and Bone Health in Young Adult Women
Prebiotics have been linked to increased calcium absorption in animal and human studies (particularly in adolescents and in premenopausal women).
Similarly, probiotics have been found to benefit calcium homeostasis in pregnant women, and to promote bio-mineralization in animal models.
The effect of symbiotic on calcium absorption has been tested in rats, but not in human studies.
The primary objective of this study is to investigate the effect of daily consumption of a functional symbiotic yogurt containing inulin and Lactobacillus rhamnosus compared to a control yogurt, on calcium absorption in young adult women.
A secondary objective is to relate changes in calcium absorption following yogurt consumption, with calcium metabolism, vitamin D status, bone mass, calcium intake and overall composition of habitual diet.
Study Overview
Detailed Description
A potential strategy to reduce the risk of osteoporosis later in life is to promote optimal bone mass during early adulthood by including in the diet functional foods that maximize the efficiency of calcium absorption.
This approach is specially important in women because of their greater risk for osteoporosis than men.
In this study, we hypothesized that the daily consumption of a yogurt containing inulin and Lactobacillus rhamnosus (symbiotic yogurt) increases the efficiency of calcium absorption in young adult women when compared to daily consumption of a yogurt of similar composition but without prebiotic or probiotic (control yogurt).
Subjects in this study will be randomly assigned to consume daily the symbiotic yogurt or the control yogurt during two 3-week periods with a wash-out period of 3-weeks, in a cross-over design.
Calcium absorption will be measured by stable calcium isotope methodology.
Bone mass (BMD, BMC) will be measured by dual-Y ray absorptiometry.
Serum intact parathyroid hormone, 25-hydroxyvitamin D and dietary intake will be measured by conventional methods.
Study Type
Interventional
Enrollment (Actual)
54
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- ages 18 to 35 years
- generally healthy
Exclusion Criteria:
- pregnancy/lactation
- BMI <18,5 kg/m2
- BMI> 29 kg/m2
- metabolic disorders, bone, liver or kidney disease that may affect calcium metabolism
- smoking
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: functional yogurt
Participants are given the symbiotic yogurt daily (180 ml)
|
|
|
Experimental: control yogurt
Participants are given the control yogurt daily (180 ml)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in calcium absorption
Time Frame: Day 21 and Day 63
|
Fractional calcium absorption measured with stable isotopes
|
Day 21 and Day 63
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Serum 25(OH) vitamin D
Time Frame: Day 1
|
Serum 25 (OH) vitamin D values expressed in nmol/liter
|
Day 1
|
|
Bone mineral content and bone mineral density
Time Frame: Day 1
|
Bone mineral content and bone mineral density values expressed as Z scores.
|
Day 1
|
|
Dietary calcium intake
Time Frame: Day 1
|
Values expressed in mg/d
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2014
Primary Completion (Actual)
December 1, 2015
Study Completion (Actual)
December 1, 2016
Study Registration Dates
First Submitted
January 12, 2018
First Submitted That Met QC Criteria
February 1, 2018
First Posted (Actual)
February 5, 2018
Study Record Updates
Last Update Posted (Actual)
February 5, 2018
Last Update Submitted That Met QC Criteria
February 1, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- URepublica 01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoporosis
-
Radius Health, Inc.CompletedOsteoporosis | Osteoporosis Risk | Osteoporosis, Postmenopausal | Osteoporosis Fracture | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of Vertebrae | Osteoporosis VertebralUnited States
-
Radius Health, Inc.CompletedOsteoporosis | Age Related Osteoporosis | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of VertebraeUnited States, Poland, Italy
-
National Taiwan University HospitalRecruitingOsteoporosis | Osteoporosis PostmenopausalTaiwan
-
Appalachian State UniversityNorth Carolina Agriculture & Technical State UniversityCompletedPostmenopausal Osteoporosis | Osteoporosis, OsteopeniaUnited States
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisUnited States
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisUnited States, Puerto Rico
-
mAbxience Research S.L.CompletedPostmenopausal Women With OsteoporosisPoland, Serbia, Bulgaria, Georgia, Estonia, Hungary, Latvia, Mexico
-
Radius Health, Inc.Nordic Bioscience A/SCompletedPost Menopausal OsteoporosisPoland, Denmark, United States, Estonia
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceRecruitingPost Menopausal OsteoporosisFrance
-
AmgenCompletedPost Menopausal OsteoporosisFrance
Clinical Trials on yogurt
-
Laval UniversityRecruitingGut Microbiota | Bone Health | Body Composition Changes | Bone Metabolism | Metabolic Health | Body Weight ChangeCanada
-
Laval UniversityNot yet recruiting
-
Jose María Maya MejíaUnknown
-
Instituto de Investigación Hospital Universitario...Go Fruselva, S.L.Completed
-
BioibericaTechnological Centre of Nutrition and HealthCompletedLow Intensity Knee GonalgiaSpain
-
Micropharma LimitedCompletedHypercholesterolemia
-
University of California, DavisRecruiting
-
Maastricht University Medical CenterUnknownOverweight and Obesity | Satiety Response | SatiationNetherlands
-
Federal University of PelotasPontificia Universidade Católica do Rio Grande do SulCompletedDental Caries | Oral HealthBrazil